Browsing by Subject "Neurological conditions"
Now showing items 1-3 of 3
-
C3 amino-substituted chalcone derivative with selective adenosine rA1 receptor affinity in the micromolar range
(Springer, 2020)To identify novel adenosine receptor (AR) ligands based on the chalcone scaffold, herein the synthesis, characterization and in vitro and in silico evaluation of 33 chalcones (15–36 and 37–41) and structurally related ... -
Synthesis and evaluation of chalcones and structurally related compounds as adenosine A₁ and/or A₂ᴀ receptor antagonists for the potential treatment of neurological conditions
(North-West University (South-Africa), 2021)"Abstract not copied" -
Synthesis and structure activity relationships of chalcone based benzocycloalkanone derivatives as adenosine a 1 and/or a 2a receptor antagonists
(Thieme, 2020)Adenosine A1 and/or A2A receptor antagonists hold promise for the potential treatment of neurological conditions, such as Parkinson’s disease. Herein, a total of seventeen benzocycloalkanone derivatives were synthesised ...
